Af.51 Vedolizumab May Be an Effective Option for the Management of Postoperative Recurrence of Crohn’s Disease
Year: 2021
Type: article
Source: Digestive and Liver Disease
Institutions: University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Azienda Ospedaliera Sant’Antonio Abate di Gallarate, IRCCS Humanitas Research Hospital, Sapienza University of Rome, Azienda Ospedaliera Bolognini Seriate, Ospedale di Circolo di Busto Arsizio, University of Milano-Bicocca, University of Brescia
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3201633949
